The Corporation focussed on the biology of healing has this week completed a C$75m equity offering and conversion of some C$229m of debt leaving a balance of just C$10m. The Company has also proposed a Rights Offering subject to TSX approval. Shareholders will have the right to subscribe is up to 20 shares for every 1 held at the same transaction price of the recently closed deals, namely 1.52 Canadian cents, a discount of 76% to the current share price and 72% to our estimated theoretical ex ....